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Abstract
Background: Because higher survival of follicles during the freezing/thawing procedure improves the quality of
cryopreserved tissue reimplanted after oncological therapies, defining an optimal method for human ovarian tissue
cryopreservation remains a major issue in this field. One option to improve the cryopreservation procedure is to use
better materials, i.e., vials with better conductivity. The aim of this study was to compare polypropylene (PP) with
quartz vials. Between September 2012 and January 2013, eight patients were recruited. The ovarian cortex was
cut into 3 slices, assigned randomly to a fresh and a cryopreserved group in PP (method B) or quartz vials
(method C). Histological and immunohistochemical (IHC) analysis were used. For IHC three antibodies were
analyzed: Ki67 (proliferation index), Bcl2 (anti apoptotic index) and Hsp70 (stress index).
Results: The majority of GCs showed positive staining for Bcl2 in both cryopreservation device, with higher
expression in group C than in group B. Oocytes and their nuclei showed intense positive staining for ki67 in both
methods B and C, and also a patch positive stromal cells staining for Ki67. Expression of hsp70 was not increased
after cryopreservation.
Conclusions: Cryopreservation using quartz vials led to larger numbers of good follicles while maintaining
consistent preservation for stromal cells and vessels.
Keywords: Rapid cryopreservation, Human ovarian tissue, Quartz vial, HSP70, Bcl2, Ki67
Background
Worldwide, at least 60 babies have been born after reim-
plantation of cryopreserved human ovarian tissue [1–4].
However, tissue cryopreservation is more complex than
single cell cryopreservation, as tissues are composed of
different types of cells with different water composition.
Thus, finding a general protocol suitable for cryopreser-
vation of ovarian tissues is challenging. Several freezing/
thawing procedures that differ in dehydration and hydra-
tion time, cryoprotectants or protein source have been
developed using different devices. Cryopreservation and
ischemia after transplantation seem to cause follicle loss;
however, the latter can be avoided by using an appropriate
micro-surgical technique [5]. Because higher survival of
follicles during the freezing/thawing procedure improves
fertility, defining an optimal method for cryopreservation
remains a major issue in this field. Here, we investigated a
rapid freeze/thaw procedure combining the positive as-
pects of both slow freezing and vitrification. Each of the
latter methods has its limitations. Slow freezing (an equi-
librium method) is a long (>3 h) and expensive procedure.
It requires significant amounts of liquid nitrogen and a
programmable freezing machine, and current methods
still cannot preserve all cortical tissue cells. In addition,
slow freezing protocols are reported to negatively affect
stromal cells, which are also important for follicle dynam-
ics. On the other hand, vitrification (a non-equilibrium
method) requires very fast cooling rates using a high con-
centration of cryoprotectants (more than 4 M), which are
generally toxic to cells.
The concentration of cryoprotectants as well as the
exposure time are important factors in improving follicle
cell survival [6]. Another option to improve the cryo-
preservation procedure is to use better materials, i.e.,
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vials with better conductivity. Compared with polypro-
pylene (PP) vials, quartz vials show better conductivity
[7, 8]. The aim of this study was to compare PP with
quartz vials and to develop a protocol for improving the
survival of follicles and stromal cells in cryopreserved
ovarian tissue.
Methods
Between September 2012 and January 2013, eight pa-
tients were recruited at the Department of Gynecology,
University Hospital of Zurich. Participation was volun-
tary, and written informed consent was obtained before
the procedure. Inclusion criterion for patient recruit-
ment was pre-menopausal status. All recruited patients
were scheduled to undergo a laparoscopic procedure for
benign conditions of the ovaries. Patient age ranged
from 19 to 37 years (mean age 31.2 ± 6.48). Small biopsies
of ovarian tissue collected from the cortex surrounding
benign cysts is a good source of ovarian tissue to study
cryopreservation procedure [9]. The study was reviewed
and approved by the Ethics Committee of Canton Zurich
(Kantonale Ethikkommission Zürich, KEK-ZH-NR: 2010-
0169/0).
Tissue preparation
For tissue harvesting, the ovarian cortex was excised in-
traoperatively with scissors without previous electro-
coagulation. The specimens were immersed and kept in
fresh basal medium composed of Leibovitz L-15 (Gibco)
and 10 % Human Serum Albumin (HSA, Sage) at room
temperature (RT), and transported to the laboratory
within 5 min.
Rapid freezing/thawing protocol
The ovarian cortex, cleaned from the ovarian medulla,
was cut into 3 thin slices, which were assigned randomly
to a fresh and a cryopreserved group. One of the slices
was fixed immediately and used for fresh histological
analysis, and the remaining pieces were cryopreserved
rapidly in three solutions with increasing cryoprotectant
concentration using the following protocol. All cryopro-
tectants were from Sigma-Aldrich: EG, ethylene glycol;
DMSO, dimethyl sulfoxide; and PROH, 1,2-propanediol.
Quartz and PP vials were refilled with solution 1, solution
2, and solution 3. Then, slices were immersed in both
tubes (Fig. 1) in solution 1 (1 M EG in Leibovitz L-15 sup-
plemented with 20 % HSA) for 8 min at RT, then passed
through solution 2 (1 M EG, 1 M PROH, 1 M DMSO,
0.3 M sucrose in Leibovitz L-15 supplemented with 20 %
HSA) for 5 min at RT, and finally equilibrated in both kind
of tubes in fresh solution 2 at 4 °C for 15 min. We decided
to use a rather long equilibration at 4 °C in step 3 in order
to minimize toxicity, and because DMSO and EG pene-
trate tissue faster at 4 °C than do PROH and glycerol
(GLY), as also suggested by Newton et al. [10]. At each
step, tubes were rolled gently to allow penetration of
cryoprotectants. All cryoprotectant solutions were filter-
sterilized and stored for a maximum of 3 days at 4 °C prior
to use. After removing all additional medium using sterile
absorbent gauze, tissues were placed in the inner wall of
sterile pre-cooled PP vials (1.8 ml NUNC cryotube,
Sigma-Aldrich; method B), or pre-cooled quartz vials ster-
ilized (H. Baumbach & Co Ltd., UK; method C), both
closed, immersed in liquid nitrogen for 30 min and then
stored in vapor storage tanks (CBS V1500-AB series).
After a month, samples were thawed rapidly within 10 s at
RT, followed by immersion in a water bath at 38 °C for
1 min. The contents of each vial were transferred at RT
into solution I (Leibovitz L-15 supplemented with 0.5 M
sucrose and 20 % HSA) for 5 min, then into solution II
(Leibovitz L-15 supplemented with 0.25 M sucrose and
20 % HSA) for 5 min, and finally into solution III (Leibo-
vitz L-15 and 20 % HSA) for 5 min, washed (3–5 times),
and then incubated (HERA cell 150, Thermo Scientific)
for 12–15 h in G-IVF medium (Vitrolife) in 6 % CO2 in
air at 37 °C. The vial was agitated gently throughout the
thawing steps. To allow immunohistochemical (IHC)
analysis, all frozen/thawed samples were incubated for
12–15 h to provide time for protein expression, but not
longer than 15 h to reduce any influence of culture on
our cryopreservation results.
Use of different vials
Follicle survival depends on cryoprotectant concentra-
tion and exposure time [6]. In this context we developed
the idea of testing a new cryopreservation protocol
(non-equilibrium procedure), i.e., a hybrid technique in
which cryoprotectant concentration is reduced with re-
spect to vitrification using a combination of factors. Firstly,
we used quartz vials instead of the more commonly used
polypropylene (PP) vials. For both quartz and PP vials we
used a closed system in which tissue never contacts liquid
nitrogen directly, in accordance with EU Directive (http://
eur-lex.europa.eu: 2004/23/EC, 2006/17/EC, 2006/86/EC).
Fig. 1 Shows the used vials: a PP vial on the right side and a quartz
vial on the left side
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Quartz (8 Wm−1K−1) has a better conductivity than PP
(0.16 Wm−1K−1) [7, 8]. Secondly, we performed the first
freezing step in 1 M EG. EG has a molar mass of
62.07 g · mol−1 [cf. DMSO 78.13 g · mol−1 and PROH
76.09 g · mol−1). Its small mass, combined with its high
permeability of 1.85 × 10−9 m2/s (cf. PROH 1.0 × 10−9
m2/s), allows EG to enter cortical tissue more easily
and faster than other cryoprotectants [11].
Histological analysis
The morphological appearance of follicles, stromal cells
and vessels were examined before and after cryopreser-
vation. Fresh and frozen/thawed ovarian tissue was fixed
in 4 % formalin, washed in 70 % ethyl alcohol, and then
processed and embedded in paraffin wax. Serial sections
4 μm thick were prepared and, for every eight sections,
three slices were mounted on glass slides (Thermo Scien-
tific). The central slice was deparaffinized, hydrated and
stained with haematoxyilin and eosin (H&E), while the
other two slices were used for IHC detection. All sections
were observed using a light microscope (Olympus, model
BX43) at magnifications from 25X to 400X, and scored
blind after assigning a random number to each slide. All
photos were taken using a light microscope (Micro Zeiss
AXIO Images) connected to a camera (Axiocam MRc5
Zeiss, controlled by Axiovision Release 4.8). To help re-
duce costs, IHC was performed only if a follicle was found
in the H&E stained slide. To avoid double counting of
follicles, only follicles containing oocytes with a visible
nucleus and granulosa cells (GCs) were evaluated. The
developmental stage of the follicle was evaluated ac-
cording to Gougeon’s criteria, and follicle morphology
was evaluated according to Keros’s modified parameters
[12, 13].
A score of one to three was given to each follicle. Level
1 corresponded to well-preserved follicles that contained
an intact oocyte in contact with the surrounding intact
GCs. Level 2 corresponded to quite well preserved follicles
that showed no more than 25 % of one or two of the fol-
lowing signs: detachment of the oocyte from surrounding
GCs, vacuolization of the cytoplasm, disorganized and
degenerated GCs, or detachment of the basal membrane.
Level 3 corresponded to degenerated follicles that showed
more than 50 % of the following signs: detachment of the
oocyte from surrounding GCs, vacuolization of the cyto-
plasm, disorganized and degenerated GCs, detachment of
the basal membrane, or having pyknotic oocyte nuclei.
Stromal cells were evaluated using a score from one to
four. Level 1 denoted very good preservation (81–100 %
undamaged nuclei, no edema, no pyknotic nuclei); level
2 denoted quite good preservation (60–80 % undamaged
nuclei, rare edema, rare pyknotic cells); level 3 denoted
very poor preservation (31–59 % undamaged nuclei,
focal edema, focal pyknotic nuclei); and level 4 denoted
bad preservation (0–30 % undamaged nuclei, diffuse
edema, diffuse necrotic stromal cells with pyknotic nuclei).
Histological evaluation was also undertaken to detect
potential micro vascular damage, using a score from one
to four: level 1 indicated good preservation (81–100 %
undamaged nuclei endothelial cells, and vascular endo-
thelium with no sign of detachment), level 2 indicated
quite good preservation (60–80 % undamaged nuclei
endothelial cells, and vascular endothelium with rare
signs of detachment), level 3 indicated very poor preser-
vation (31–59 % undamaged nuclei endothelial cells, and
vascular endothelium with focal signs of detachment),
and level 4 indicated bad preservation (0–30 % undam-
aged nuclei endothelial cells, and vascular endothelium
with diffuse sign of detachment).
Immunohistochemical analysis
We used semiquantitative IHC analysis to evaluate the
preservation of stromal cells, follicles and vessels sub-
jected to rapid freezing/thawing (methods B and C)
compared to a fresh sample as a control (method A).
Immunohistochemical evaluation was based on a modified
classification according to Fabbri et al. (diffuse, patch, or
focal pattern of the ICH staining) [14]. Three antibodies
were analyzed: Ki67, Bcl2 and Hsp70. The Ki67 antibody
(Cell Marque Lifescreen Ltd., 1:300 dilution) recognizes a
nuclear structure expressed during all active phases of the
cell cycle (G1, S, G2 and mitosis) except in quiescent or
resting cells (G0 phase); Ki67 act as a cellular marker for
cellular proliferation, and is an excellent index with
which to evaluate the potential growth fraction of a tis-
sue in research and diagnostics [15]. The Bcl2 antibody
(Novocastra laboratories Ltd, 1:200 dilution) recognizes
a mitochondrial membrane protein that blocks pro-
grammed cell death, and thus acts as an anti-apoptotic
index. The Hsp70 antibody (Invitrogen BV, 1:400 dilution)
is expressed during different kinds of stress, and acts as a
stress index. Specificity of staining was confirmed by a
detection-system tested for unspecific staining on human
tissue, and by positive controls from a multi-tissue Array.
The grade of immunohistochemical positivity was evalu-
ated according to Fabbri’s modified parameters as: diffuse
(≥ than 50 % of cells are positive), patch (20–50 % of cells
are diffusely positive), and focal (<20 % of cells are positive
in fewer zona).
Statistical analysis
Data were described as numbers and percentages, or
mean and standard deviation, as appropriate. Histological
results were analyzed statistically. Statistical evaluation
was undertaken using Intercooled Stata 11.0 (StataCorp
LP, College Station, TX) by means of Fisher’s exact test for
categorical data. P-values below 0.05 indicate statistical
significance (two-sided).
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Results
Histological results
Table 1 shows the summary of the histomorphological
analysis of preservation for follicles, stromal cells, and
vessels in fresh ovarian tissue, rapid frozen/thawed tissue
in PP vial and in quartz vial. A total of 72 follicles at dif-
ferent stages were analyzed: 41.7 % at primordial stage,
16.7 % intermediary, 33.3 % primary, 5.5 % secondary,
and 2.8 % pre-antral and antral stage. 58.4 % of the folli-
cles were at the “resting stage”. Morphological analysis
of the follicles revealed better preservation with method
C (quartz vials) than with method B (PP vials) (92.3, and
36.4 %, respectively). Quartz vials lead to a statistically
significantly higher preservation score than method B
(p = 0.008).
The examination of the morphology of stromal cells
(score 1 and 2) revealed a comparable preservation for
both methods (PP vials 91.7 %, and quartz vials 89.5 %,
resp.; p = 0.55).
Similarly, the morphology of vessels was preserved
(score 1 and 2) in all cryopreserved tissue with no statis-
tically significant differences (PP vials 45.0 %, and quartz
vials 63.6 %, resp.; p = 0.54). Results are obtained by HE
staining as shown in Fig. 2.
Immunohistochemical results
The majority of GCs showed positive staining for Bcl2
in both cryopreservation methods (B and C), with higher
expression in group C (quartz vials) than in group B (PP
vials) (Fig. 3). Oocytes and their nuclei showed intense posi-
tive staining for ki67 in both methods B and C (Fig. 3).
A high percentage of both stromal cells and vessels
were stained for Bcl2 in method B and C (Fig. 3). In both
kinds of vials, patch positive staining for Ki67 was ob-
served in stromal cells.
Expression of hsp70 was not increased after cryo-
preservation, although fresh tissue showed a diffuse
positivity compared to frozen tissue (Fig. 3).
Discussion
Currently, the standard procedure for ovarian tissue cryo-
preservation is a slow freezing followed by rapid thawing
protocol. However, the long duration (>3 h) needed to
achieve the required slow reduction in temperature, and
the use of a significant amount of liquid nitrogen is disad-
vantageous. Also, even slow freezing cannot avoid ice crys-
tal formation with the associated negative effect on oocyte
survival. In addition, many authors also report suboptimal
stromal cell preservation during slow freezing [13, 16]. A
disadvantage of vitrification procedures is the use of very
high cryoprotectant concentrations (more than 4 M),
reaching cytotoxic levels.
Our study focuses on a new, rapid cryopreservation
protocol that avoids the disadvantages of slow freezing
and vitrification, with the aim of achieving high recovery
of all cells presented in ovarian cortical tissue as a pre-
requisite for optimum transplantation functionality. We
evaluated a faster freezing procedure that avoids high –
and thus cytotoxic – cryoprotectant concentrations. Of
the cryoprotectants tested, EG has the lowest molecular
mass. Another important factor in our method is that
the thermal conductivity of quartz is higher than that of
PP. Thus, we directly tested the effects of quartz during
our rapid cryopreservation procedure. Quartz has been
tested successfully in oocytes using special quartz capil-
laries [7, 8, 17, 18].
Table 1 Histomorphological analysis of preservation for follicles, stromal cells, and vessels in fresh (A) ovarian tissue, rapid frozen/
thawed tissue in PP vial (B), and in quartz vial (C)
Preservation Score A - fresh ovarian tissue B - rapid frozen/thawed tissue
in PP vial
C - rapid frozen/thawed tissue in
quartz vial
P (Fisher’s exact test)
Follicles 1 9 (90 %) 4 (36.4 %) 12 (92.3 %) 0.004*
2 1 (10 %) 7 (63.6 %) 1 (7.7 %)
3 0 0 0
Stromal cells 1 10 (62.5 %) 13 (54.2 %) 9 (47.4 %) 0.80
2 6 (37.5 %) 9 (37.5 %) 8 (42.1 %)
3 0 (0 %) 2 (8.3 %) 2 (10.5 %)
4 0 (0 %) 0 (0 %) 0 (0 %)
Vessels 1 5 (38.5 %) 2 (10 %) 1 (9.1 %) 0.16
2 6 (46.1 %) 7 (35.0 %) 6 (54.5 %)
3 2 (15.4 %) 5 (25.0 %) 3 (27.3 %)
4 0 (0 %) 6 (30.0 %) 1 (9.1 %)
For follicle preservation, score 1 is considered as well preserved, score 2 as quite good preserved, and score 3 as degenerated follicles. For stromal cells and
vessels, scores 1 + 2 are considered as well preserved, score 3 as not optimal preservation, and score 4 as degenerated stromal cells or degenerated vessels, resp
Data are presented as numbers and percentage (in brackets)
*) Method B differs significantly from C (two sided Fisher’s exact test, p = 0.008)
Scheiner et al. Journal of Ovarian Research  (2016) 9:59 Page 4 of 8
Both the cryoprotectant penetration rate and the
temperature play important roles during the cryoprotect-
ant procedure; a compromise between cryoprotectant
concentration, incubation time and temperature is re-
quired [19].
A first freezing step using only the smallest cryopro-
tectant (EG) combined with a quartz vial as support re-
sulted in more rapid penetration, decreasing both
exposure time and cytotoxicity.
Our morphological results showed better preservation
of follicles with Quart vials (method C) compared to PP
vials (method B). Frozen/thawed stromal cells were com-
pared to fresh controls in both methods. These histo-
logical results agree with the results of IHC, observing
the distribution and relative amounts of Bcl2, Ki67, and
HSP70 in human cortical tissue. Ki67 and Bcl2 were also
tested by previous authors as markers for preservation
during freezing/thawing procedures [14, 20, 21].
Diffuse positivity for Bcl2 in GCs, stromal cells, and
vessels observed after cryopreservation in both devices
confirmed that these cells are not in a state of apoptosis.
In vessels, Bcl2 is also involved in production of vascular
endothelium growth factor (VEGF) as reported by Sasi et
al. [22]. Thus, diffuse positivity observed in vessels could
indicate not only an inhibition of apoptosis but also an in-
duction of vascular endothelium growth crucial for proper
transplantation of cryopreserved ovarian tissue.
Diffuse positive staining of Ki67 in oocytes and their
nuclei, and patch positive staining in stromal cells con-
firmed that these cells are in a growing phase and not in
G0 of the cellular cycle. However, a few cells staining
positive for ki67 were observed in GCs. Choi reported
that ovarian tissue cryopreservation suppresses GC pro-
liferation, and that this impairment is recovered within
48 h after culture [23]. This was confirmed in our study,
with a few positive GCs staining for Ki67 after cryo-
preservation. This may be because tissue was fixed after
12–15 h of culture and this time is possibly insufficient
for GC recovery. It might also depend on the natural
disappearance of follicles during follicular growth and
development, which involves primarily the apoptosis of
GCs; this plays a major role in follicular atresia. Thus,
only a limited number of primordial follicles develop to
the pre-ovulatory stage and ovulate, the majority of folli-
cles are eliminated throughout their normal reproductive
life cycle [24, 25].
The HSP family is known to be induced in response to
cellular stresses, including changes in temperature and
Fig. 2 Light microscopy images of cortical human ovarian tissue stained with haematoxylin-eosin from fresh (control) tissue (a, d, g), cryopreserved in
PP device (b, e, h) and cryopreserved in quartz device (c, f, i). Stromal cells in cryopreserved tissue using PP (b) or quartz (c) vial are good preserved
and compared to fresh tissue (a). Vessels shows a quite good preservation using PP (e) or quartz (f), even if in PP it is observed a significant lower
amount of well-preserved vessels compared to fresh tissue (d). It is observed in follicles a good preservation after cryopreservation in both devices, even
if quartz (i) has a significant high good preservation compared to PP (h). Follicles stages show in G two primary follicles, in H one intermediary, and in I
a secondary follicle. (Magnification from 100× to 400×)
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ischemia [26]. Thus, HSP70 may be used as a bio-
indicator to monitor the impact of environmental factors
on an exposed organism, including on the reproductive
organs [27]. However, in this study, positive Hsp70 stain-
ing was seen in both fresh and cryopreserved stromal
cells, with no increased level of expression observed after
Fig. 3 Representative images of immunohistochemical analysis of Bcl2, Ki67 and HSP70 levels in cortical human ovarian tissue. a microphotography
shows Bcl2 staining in fresh stromal cells, compared to cryopreservation tissue in PP (b) and quartz (c). For follicles a positive Bcl2 staining was found in
GCs after cryopreservation in PP (d) and quartz (e). Vessels evaluation shows a positive staining for Bcl2 both in fresh tissue (f) and cryopreserved tissue
using PP (h) or quartz vial (g). For ki67 a positive staining after cryopreservation is shown in the nuclei like in the ooplasm using PP vial (i) and quartz
vial (l). For hsp70 a diffuse positive staining in stromal cells is shows in fresh (m) and cryopreserved tissue using PP (n) or quartz devices (o). Cells
stained positive for Bcl2, Ki67, HSP70 are brown, compared with the blue counterstained cells. Magnification from 25× to 400×
Scheiner et al. Journal of Ovarian Research  (2016) 9:59 Page 6 of 8
cryopreservation compared to the fresh control. The ex-
pression also in fresh tissue could be due to an overex-
pression correlated to the pathogenesis of cystic disease
[28], as all our analyzed cortical tissue came from patients
affected by ovarian cysts. Alternatively, it could be due to
a constitutive expression of hsp70 observed in human cells
also under normal physiological conditions [29].
Conclusion
This is the first study to test quartz property as device
on ovarian tissue cryopreservation procedure. Based on
these data it can be concluded that quartz is a better
material for cryopreservation than PP. Using quartz vials
led to larger numbers of good follicles with comparable
results for both stromal cells and vessel preservation.
We hypothesize that this may be because quartz material
can maximize the cooling rate. These promising results
suggest that this cryopreservation protocol is efficient
and could be a suitable technique for ovarian tissue
cryopreservation if quartz vials are used. However, fur-
ther clinical studies on a larger patient group are neces-
sary in order to evaluate follicle genetic damage after
cryopreservation, and to validate functional recovery
using ovarian xenografting.
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